Stacie Canan Koch

Title: Stacie Canan Koch: Innovator in Retinoid X Receptor Modulation

Introduction

Stacie Canan Koch is a prominent inventor based in San Diego, CA. She has made significant contributions to the field of biochemistry, particularly in the modulation of retinoid X receptors. Her innovative work has led to the development of compounds that selectively target these receptors, which play a crucial role in various biological processes.

Latest Patents

Stacie holds a patent for "Compounds having selective activity for retinoid X receptors, and means for modulation of processes mediated by retinoid X receptors." This patent describes compounds, compositions, and methods for modulating processes mediated by retinoid X Receptors using retinoid-like compounds. These compounds exhibit selective activity for members of the subclass of Retinoid X Receptors (RXRs), as opposed to members of the subclass of Retinoic Acid Receptors (RARs). Examples of such compounds include bicyclic benzyl, pyridinyl, thiophene, furanyl, and pyrrole derivatives. The disclosed methods utilize these compounds to modulate processes selectively mediated by Retinoid X Receptors.

Career Highlights

Stacie is currently associated with Ligand Pharmaceuticals, Inc., where she continues to advance her research and development efforts. Her work has garnered attention for its potential applications in therapeutic areas, particularly in the modulation of gene expression and cellular processes.

Collaborations

Stacie has collaborated with notable colleagues, including Marcus F. Boehm and Richard Alan Heyman. These partnerships have contributed to the advancement of her research and the successful development of innovative compounds.

Conclusion

Stacie Canan Koch is a trailblazer in the field of retinoid X receptor modulation, with a patent that highlights her innovative contributions. Her work at Ligand Pharmaceuticals, Inc. and collaborations with esteemed colleagues underscore her impact on biochemistry and therapeutic development.